Most menopause advice is written as though the transition runs the same course for every woman. The largest long-running study of the transition found otherwise — differences in when it starts, how long symptoms last, and how severe they are. Those differences matter, and they sit alongside documented gaps in who actually gets treated.

Where we stand: Menova is an independent publication. We sell no hormones, we are not your doctor, and this is general education, not a diagnosis. The findings below are population patterns from research, not predictions about any individual — and they are averages that individuals routinely fall outside of.

Where the evidence comes from

The Study of Women's Health Across the Nation (SWAN) has followed a large, multi-ethnic group of US women through the transition for decades. It is the main reason we know these differences exist at all, and it is worth naming because much older menopause research was conducted almost entirely in white populations — which is part of why "typical menopause" has been described so narrowly.

What SWAN found

Timing. Age at menopause differs across groups. SWAN reported that Black and Hispanic women reached menopause earlier on average than white women, with Chinese and Japanese women in a broadly similar range to white women. The differences are in the order of months to a couple of years rather than decades — but earlier menopause is itself associated with longer cumulative estrogen deficiency, which matters for bone and cardiovascular health.

Duration of hot flashes. This is the most striking finding. Across all women, vasomotor symptoms lasted a median of around seven years. But the median duration differed substantially by group — longest in Black women, at around ten years, and shortest in Japanese and Chinese women, at around five to six. White and Hispanic women fell between.

Severity and symptom profile. Black women in SWAN reported more frequent and more bothersome vasomotor symptoms. Chinese and Japanese women reported fewer vasomotor symptoms but were more likely to report other symptoms, including joint and muscle stiffness.

Sleep and mood also varied, with reported patterns differing across groups in ways that do not map neatly onto the vasomotor findings.

What this does and does not mean

Two things worth holding together.

It is not simply biology. Researchers consistently point out that these differences are entangled with socioeconomic factors, chronic stress including the physiological effects of experienced discrimination, body composition, smoking rates, and access to care. SWAN itself has published on the association between reported discrimination and menopausal symptom burden. Treating the differences as fixed racial traits misreads the evidence.

It is not a prediction about you. These are medians across thousands of women. Plenty of Black women have a short, mild transition and plenty of Japanese women have a decade of severe hot flashes. Your own pattern is your own.

The treatment gap, stated plainly

Alongside the symptom findings sits a harder one: Black women in the US are less likely to be prescribed hormone therapy than white women, despite reporting more frequent and longer-lasting vasomotor symptoms. Studies of prescribing patterns have found this repeatedly.

The explanations offered include differences in access to specialist care, insurance, whether symptoms are raised and how they are received, and documented disparities in how women's symptoms are assessed generally. Whatever the mix, the practical consequence is the same: the group with the heaviest symptom burden is not the group receiving the most treatment.

Naming that is not a reason for despair. It is a reason to walk in prepared and to ask directly, because a specific, documented request is much harder to defer than a vague one — see not being dismissed.

What to do with this

If your symptoms have lasted longer than the "few years" you were promised, that is consistent with the data rather than a sign something is wrong with you. A median of seven years overall, and around ten in Black women, is the real figure — see how long perimenopause lasts.

If you reached menopause early, that has implications worth acting on for bone and cardiovascular health, and it changes the treatment calculation — see early and surgical menopause.

If your main symptoms are joint and muscle stiffness rather than hot flashes, that is a recognized pattern and not a reason to be told you are not in the transition — see menopause joint pain.

If you have been offered nothing, ask specifically: "Given how frequent and how long-standing my symptoms are, could we discuss hormone therapy — and if it's not appropriate for me, what non-hormonal options would you consider?" Both halves matter; see HRT risks and benefits and non-hormonal prescription options.

The things that are the same for everyone

Worth saying, because differences can obscure the common ground:

  • Cycle change plus clustered symptoms is how the transition is recognized at any age and in any group
  • Vaginal and urinary symptoms progress without treatment rather than settling; see GSM and urinary changes
  • Thyroid disease, iron deficiency, and sleep apnea mimic menopause in everyone and are worth ruling out; see when menopause might not be the answer
  • Bone and cardiovascular risk rise after menopause regardless of when it arrived
  • Walking in with a written record changes the conversation more than any other single factor

Bring the evidence

If longer or heavier symptoms are your experience, the most useful thing you can do is document them — frequency, severity, and how long they have been going on. "Fourteen hot flashes a day for four years, waking four times a night" is a clinical picture. "I'm still getting them" is not.

Our free 30-day symptom tracker produces that record, the free printable visit prep sheet condenses it to one page, and the free 2-minute self-check gives you a summary to bring. No account, not a diagnosis, and your answers never leave your device.

If you are getting nowhere locally, our guides to finding a clinician who knows menopause and our comparison of menopause telehealth cover the alternatives — several services operate in all 50 states, which matters when local specialist access is the barrier.

This article is general education, not medical advice or a diagnosis. Population-level research findings do not predict an individual's experience. Discuss your symptoms with a licensed clinician.

Sources: Study of Women's Health Across the Nation (SWAN), The Menopause Society, National Institute on Aging, and ACOG.